NCT05175300 Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject
| NCT ID | NCT05175300 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Hip Arthropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-03-24 |
| Primary Completion | 2032-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-03-24 with a primary completion date of 2032-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Interest of a highly cross-linked polyethylene acetabular component doped with vitamin E in total hip arthroplasty of the young and active subject.
Eligibility Criteria
Inclusion Criteria: * Patient aged 18 to 65 years, * Who have signed their consent to participate in the study, * For whom an indication for total hip arthroplasty has been given Exclusion Criteria: * History of hip surgery * Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly) * Hip dysplasia * Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis * Sequelae of neurological disease or stroke * Pregnant or breastfeeding women * Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol * Patient likely not to return for follow-up visits * Patient already included in another therapeutic study protocol * Patient under court protection, guardianship or curatorship.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05175300 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Hip Arthropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05175300 currently recruiting?
Yes, NCT05175300 is actively recruiting participants. Contact the research team at jeangast@gmail.com for enrollment information.
Where is the NCT05175300 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT05175300 clinical trial?
NCT05175300 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 100 participants.